Summary Safety Review - Gabapentin - Assessing the Potential Risk of Serious Breathing Problems

Summary Safety Review - Gabapentin - Assessing the Potential Risk of Serious Breathing Problems is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2024-05-09. On CanQuery you can follow the original downloads. Files are available in English and French.

In 2014, the product information for gabapentin products was updated to warn about the risk of serious breathing problems (respiratory depression) when it is used with an opioid. While reviewing safety information given by the manufacturer for this change, Health Canada found cases of respiratory depression in patients treated with gabapentin alone. Therefore, this current safety review was carried out to assess the possibility of the same concerns in patients using gabapentin alone (when not taken with opioids) and to find out if more safety measures were needed.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2024-05-09

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data